Stem Cell Cord Blood 'Banking' Is Huge Global Business for Hospitals, Says CEO of Bio-Matrix Scientific ... ( SAN DIEGO July 10 /- David Koos Chair...)

Stem Cell Cord Blood 'Banking' Is Huge Global Business for Hospitals, Says CEO of Bio-Matrix Scientific Group Inc.

Date:7/10/2009

SAN DIEGO, July 10 /PRNewswire-FirstCall/ -- David Koos, Chairman and CEO of San Diego-based Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN), today said that he believes that stem cell cord blood banking is a "huge business opportunity for hospitals worldwide." The Bio-Matrix CEO stated that hospitals throughout the world are now eagerly starting their own stem cell cord blood banks. "Hospitals from the U.S. to India are naturally interested in providing cord blood banking facilities to their patients and the overall awareness of this stem cell storage banking concept is catching on fast." Bio-Matrix recently announced a new company marketing program aimed specifically at hospitals and research centers interested in using its 15,000 square foot stem cell storage bank facility in San Diego.

According to Koos, "Companies like Bio-Matrix are making use of a ready-made patient customer base by linking up with hospitals, medical institutes, research institutions and biotechnology companies to assist in stem cell research and treatments. For hospitals, this kind of marketing partnership is synergistic at its roots because hospitals would promote cord blood storage banks leading to additional revenue from every newborn baby delivered. Many hospitals are starting this kind of cord blood business as part of their gynecological services because it's a natural extension of the basic service hospitals provide already and is a cash-rich add on as well."

Koos said that BMSN intends to expand its own marketing program to include stem cell therapy centers. "We are looking for strategic alliances with hospitals and research centers on a global level. The Company believes it can assist these medical institutions in better educating parents about cord blood banking. We are also in the midst of identifying regional and local partners whom we can work with."

About Bio-Matrix Scientific Group

'/>"/>

SOURCE Bio-Matrix Scientific Group Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
2. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
3. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
4. The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes
5. CDC Awards NATT Funding to Improve Blood Clot Awareness
6. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
7. Cellestis Receives FDA Approval for Blood Test for Detecting Tuberculosis
8. Blood Donations in U.S. Testing Positive for Chagas Disease
9. One of Nations Oldest Blood Services Providers Turns to Sysmex America
10. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
11. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test

Post Your Comments:

(Date:11/20/2009).... 20 Veridiam (www.veridiam.com) w...ompany category at the 2009 Workplace Excellence A...ociety for Human Resources Management and recogniz...ices. ,, Veridiam was one of nine winners, sele...es, honored at the recent awards ceremony. San Die...

(Date:11/20/2009)...OLM, November 20 Karolinska Develo...ent Fund (EIF) has entered into a,co-investment ag...ill be,managed by Karolinska Development and used ...e pharmaceutical and medical technology companies....nvestment fund. The agreement,represents EIF,s lar...

(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr. Domini...he Role of Process Analytical Technology (PAT) in ...cember 1, 2009. , (PRWEB)...ess Analytical Technology (PAT) in Green Chemistry...cess Analytical Technology (PAT) case studies will...

(Date:11/19/2009)...19 Omeros Corporation (N... results for the third quarter ended September 30,...09, Omeros reported a net loss of $3.9 million, or...4 million, or $2.54 per share, for the same period...2009, the Company reported a net loss of $15.5 mil...

Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2 Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2 Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3 Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7 Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8

[1] Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category [0] Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation [0] Process Analytical Technology (PAT) in Green Chemistry and Green Engineering [0] Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights

...-Guided IMRT to Spare Healthy .... 16 Doctors at cancer,treatment centers in the U...head and neck cancer using RapidArc(TM) radiothera...VAR ). RapidArc was used to deliver ultra-precise,...T) significantly faster,than was previously possib...

...uticals, Inc. (Nasdaq: BCRX ) today announced tha...resident of BioCryst, will present,a corporate upd...e in New,York on Tuesday, September 23, 2008 at 2:... cast of the presentation may be accessed on,the B...esentation will be,archived for 30 days., About B...

... MIGENIX Inc. (the,"Company" or "MIGENIX") (TSX: M...gs for infectious diseases, reports financial resu...rovides a corporate update on its programs,and oth... Omiganan 1% gel (Omigard(TM)/CPI-226/MX-226; top...ted infections): Cadence Pharmaceuticals, Inc.,("C...

Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck BioCryst to Present at UBS 2008 Global Life Sciences Conference MIGENIX Reports First Quarter Fiscal 2009 Financial Results

(Date:11/20/2009)...s about the health benefits of having a life partn... where amino acids known as cysteines are much mor...d up with other cysteines. , Now, researchers at... in Belgium, have discovered a new antioxidant sys...ppears in the Nov. 20 issue of the journal Scienc...

(Date:11/20/2009)...tists from the Marine Biogeochemistry and Geology ...ratory (NRL) organized and led a team of universit...n to initiate methane hydrate exploration in the B... sediment contribution to Arctic climate change. ,... as a research platform, three cross-shelf transec...

(Date:11/20/2009)...ial gene into yeast, researchers from Delft Univer...ee improvements in bioethanol production from agri...te and elimination of the major by-product glycero...ientific journal Applied and Environmental Microb...the yeast Saccharomyces cerevisiae from sugars obt...

Breaking Biology News(10 mins):Saving the single cysteine: New antioxidant system found 2 International expedition investigates climate change, alternative fuels in Arctic 2 Delft breakthrough in bioethanol production from agricultural waste 2 Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 55137 1 Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 55137 2 Advanced Instruments Introduces Next Generation Web Site 13665 1 Advanced Instruments Introduces Next Generation Web Site 13665 2 CareTech to Provide Web Services to Blessing Health System 55135 1 CareTech to Provide Web Services to Blessing Health System 55135 2 CareTech to Provide Web Services to Blessing Health System 55135 3 CareTech to Provide Web Services to Blessing Health System 55135 4

[0] Saving the single cysteine: New antioxidant system found [0] International expedition investigates climate change, alternative fuels in Arctic [0] Delft breakthrough in bioethanol production from agricultural waste

...ter wi-fi, music over the internet, pitch percepti... favorite salmon, detecting dangerous swimmers, he...hm and movement disorders, visualizing the sound o...to save manatees from collisions with boats. , T...at the 156th meeting of the Acoustical Society of ...

...t Professor of Biomedical Engineering and Orthoped...oundation New Scholar in Aging by The Ellison Medi...s invited to nominate two faculty members to submi...ed for this award after an internal competition. N...s being granted out of 97 applicants. Dr. Alsberg ...

...screened known drugs and identified small molecule...nes, which can have dangerous side effects. This n... from fibroblasts, a general cell type that is abu...including skin. , The study was published in the ...e journal Cell Stem Cell. , "Our study shows fo...

Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award Scripps research scientists identify compounds for stem-cell production from adult cells

Rabbit Anti-Human CHYMOTRYPSIN Polyclonal Antibody, Unconjugated from AbD Serotec

rNeural Stem Cell (rNSC)Kit from AlphaGenix, Inc.

Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec

4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)

Biology Products:

Rabbit Anti-Human CHYMOTRYPSIN Polyclonal Antibody, Unconjugated from AbD Serotec rNeural Stem Cell (rNSC)Kit from AlphaGenix, Inc.Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec 4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)

Stem Cell Cord Blood 'Banking' Is Huge Global Business for Hospitals, Says CEO of Bio-Matrix Scientific ...( SAN DIEGO July 10 /- David Koos Chair...)